Search
for
Sort by
Research 421–450 of 1000+
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- Drug Armamentarium for alopecia areata
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- Review of the Literature: Topical JAK Inhibitors Showing Promise for Hair Loss!
- Arzneimitteltherapie der Alopezien
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- 77200 Infections and Therapy Lapses Predominate as Flare Triggers on Oral JAK Inhibitors for Alopecia Areata: A Retrospective Cohort Study
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases
- BH21 Efficacy and safety of oral Janus kinase inhibitors in the treatment of alopecia areata: a systematic review and meta-analysis
- Clinical positioning and future prospects of JAK inhibitors in alopecia areata
- Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score
- Baricitinib-loaded EVs promote alopecia areata mouse hair regrowth by reducing JAK-STAT-mediated inflammation and promoting hair follicle regeneration
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Janus kinase (JAK)
- Expression of Signal Transducer and Activator of Transcription-3 in Androgenetic Alopecia: A case control study
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Evidence for the off-label use of tofacitinib in alopecia areata
- JAK Inhibitors in the Treatment of Lichen Planopilaris
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- VITILIGO: WHAT’S OLD, WHAT’S NEW?
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- Efficacy of JAK inhibitors in the treatment of alopecia: A case report of 10 patients
- APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up